What 3D-Printed / Additively Manufactured Medical Devices - Regulatory & Quality Requirements (2026) requires
Additively manufactured (3D-printed) medical devices require specific regulatory controls covering design validation, material qualification, process validation, post-processing, sterility assurance, and patient-specific customization. Regulators treat them as custom or patient-specific devices with heightened requirements for traceability, reproducibility, and post-market surveillance. Point-of-care manufacturing adds additional oversight layers.
Pillar: Medical & Healthcare · Authority: FDA, EU Commission, TGA, ISO/ASTM · Version: 1.0.0 · Last updated:
Primary source: https://www.fda.gov/medical-devices/3d-printing-medical-devices
SHA-256 integrity: 55bfa472fd97a13cb6c4380e0e6f7fe95be2e45977876795e5a21644da6581a4
Primary Citations — 4 traced to source
- FDA Technical Considerations for Additive Manufactured Medical Devices (2024-2026 updates)
- EU MDR Annex I General Safety and Performance Requirements (3D printing specific)
+ 2 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/3d-printed-medical-devices-2026.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/3d-printed-medical-devices-2026.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/3d-printed-medical-devices-2026
- Back to registry: Browse all 10,090 compliance nodes